The challenge: Robust epidemiology is foundational to everything you do from development decisions and launch sequencing to access planning.
Ensuring that you have the most comprehensive view allows you to plug gaps, analyze trends and proactively deal with challenges as you make key clinical decisions and plan your access strategy.
The solution: We rank and utilise publications, registries (where available) and expert insight to deliver a comprehensive view of your disease area and target indication. By collecting disease state transition probabilities and applying statistical methods, we develop predictive algorithms to support economic modelling and long-term planning. We ensure you have the strongest evidence at every stage.
- A fully adaptable epidemiological model
- Identification of key sources
- Gap analysis and strategic insights to support investment decision and access planning